Fiberoptic Bronchoscopy during Nasal Non-Invasive Ventilation in Acute Respiratory Failure

Background: Various methods have been described for safely performing fiberoptic bronchoscopy (FB) while applying non-invasive positive pressure ventilation (NIPPV) in patients with acute respiratory failure (ARF). Objectives: To evaluate the safety of a new method to perform FB in patients with ARF...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiration 2010-01, Vol.80 (4), p.321-326
Hauptverfasser: Chiner, E., Sancho-Chust, J.N., Llombart, M., Senent, C., Camarasa, A., Signes-Costa, J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Various methods have been described for safely performing fiberoptic bronchoscopy (FB) while applying non-invasive positive pressure ventilation (NIPPV) in patients with acute respiratory failure (ARF). Objectives: To evaluate the safety of a new method to perform FB in patients with ARF. Methods: Patients with ARF in whom FB was indicated were studied. The primary end-point was a mean drop in oxygen saturation (S a O 2 ) after the procedure. During nasal NIPPV, FB was performed via the mouth using a bite block sealed with an elastic glove finger allowing bronchoscope insertion. Results: Thirty-five patients were included in the final study (63 ± 17 years, 74% men, P a O 2 /F i O 2 ratio 168 ± 63). A total of 35 bronchoaspirates, 21 protected brushings, 11 bronchoalveolar lavages and 8 bronchial biopsies were done. The cardiorespiratory variables at the start and end of FB were: S a O 2 93 ± 3 to 94 ± 5%, heart rate 95 ± 17 to 99 ± 22 b.p.m. and respiratory rate 24 ± 11 to 25 ± 11 respirations/min. The lowest S a O 2 value reached during the procedure was 86 ± 3% and the maximal ETCO 2 rise was 41 ± 4 mm Hg. Leakage was
ISSN:0025-7931
1423-0356
DOI:10.1159/000314074